Lung Adenocarcinoma Metastatic
6 clinical trials · Condition
◉ Watch Lung Adenocarcinoma Metastatic
| Record | Firm | Date |
|---|---|---|
| Durvalumab (MEDI4736) in Frail and Elder Patients With Metastatic NSCLC (DURATION) (NCT03345810) | AIO-Studien-gGmbH | 2017-12-14 |
| Fostering Efficacy of Anti - PD-1 - Treatment: Nivolumab Plus Radiotherapy in Advanced NSCLC (NCT03044626) | AIO-Studien-gGmbH | 2017-02-10 |
| A+C in Metastatic Lung Adenocarcinoma Cancer (NCT02946359) | Chinese PLA General Hospital | 2016-07-01 |
| EGFRdelEx19 and KRAS Exon 2 Mutation Detection in EBUS-TBNA (NCT02975752) | University Hospital, Essen | 2015-03-01 |
Track Lung Adenocarcinoma Metastatic automatically
Every clearance here is in the API, with alerts when new ones post.